Table 1. Characterization of VTE patients.
| Analyzed VTE patients | 611 (100%) |
| Demographic data | |
| Age [years] (IQ-Range) | 75 (69;81) |
| Females | 278 (45%) |
| VTE extent | |
| Distal DVT only | 51 (8%) |
| Proximal DVT ± distal DVT | 133 (22%) |
| PE ± DVT | 427 (70%) |
| Medical history | |
| Provoked index VTE | 209 (34%) |
| Active cancer | 127 (21%) |
| Severe infection/sepsis during the last 3 months | 52 (9%) |
| Inflammatory bowel disease | 18 (3%) |
| Acute rheumatic disease during the last 3 months | 20 (3%) |
| Diabetes mellitus | 97 (16%) |
| Arterial hypertension | 388 (64%) |
| Chronic lung disease | 80 (13%) |
| Chronic or acute heart failure | 78 (13%) |
| History of major bleeding | 63 (10%) |
| Anemia* | 257 (42%) |
| Renal failure (GFR < 30ml/min) | 35 (6%) |
| Body mass index (IQ-range) | 26.2 (24.0;29.7) |
| Medication | |
| Concomitant antiplatelet therapy | 194 (32%) |
| Initial vitamin K antagonist therapy | 523 (86%) |
| Initial parenteral anticoagulation | 590 (97%) |
| Laboratory parameters | |
| Leukocytes [K/μl] (IQ-Range)* | 8.3 (6.5;11.1) |
| Platelets [K/μl] (IQ-Range)* | 213 (168;275) |
| us-CRP [mg/L] (IQ-Range)* | 24.4 (8.5;63.9) |
| D-dimer [ng/mL] (IQ-Range)* | 2517 (1634;3784) |
Baseline characteristics of analyzed patients at index VTE. Medication indicates the type of therapy applied upon diagnosis of acute VTE. Data presented as n (%) or median with interquartile (IQ)-range.
*Missing values: Anemia (n = 33), Renal Failure (n = 43), BMI (n = 5), Leukocytes (n = 34), Platelets (n = 32), us-CRP (n = 3), D-dimer (n = 21).